Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 822-826

  Thomson, Scott A ^a   Elliott, Suzanne L ^a   Sherritt, Martina A ^a   Sproat, Kathryn W ^b   Coupar, Barbara E H ^b   Scalzo, Anthony A ^c   Forbes, Catherine A ^c   Ladhams, Andrew M ^a   Mo, Xiao Y ^d   Tripp, Ralph A ^d   Doherty, Peter C ^d   Moss, Denis J ^a   Suhrbier, Andreas ^a,e  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d St Jude Children's Research Hospital   (United States)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENDAI VIRUS; THYMOMA; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; DRUG DESIGN; EPITOPES; GENETIC VECTORS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PROTEIN ENGINEERING; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 8944252799     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:59.
2. Moss, D. J., C. Schmidt, S. L. Elliott, A. Suhrbier, S. R. Burrows, and R. Khanna. 1996. Strategies involved in developing an effective vaccine to EBV-associated diseases. Adv. Cancer Res. 69:213.
3. Slingluff, C. L., D. F. Hunt, and V. H. Engelhard. 1994. Direct analysis of tumor-associated peptide antigens. Curr. Opin. Immunol. 6:733.
4. + cytolytic T cells and confers protection to infection. Immunol. Lett. 40:101.
5. Udnayakumar, V., Y. P. Shi, S. Kumar, D. L. Jue, R. M. Wohlhueter, and A. A. Lal. 1994. Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic T cell recognition. Infect. Immun. 62:1410.
6. Perkus, M. E., J. Tartaglia, and E. Paoletti. 1995. Poxvirus-based vaccine candidates for cancer, AIDS and other infectious diseases. J. Leukocyte Biol. 58:1.
7. Shen, H., M. K. Slifka, M. Matloubian, E. R. Jensen, R. Ahmed, and J. F. Miller. 1995. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc. Natl. Acad. Sci. USA 92:3987.
8. Waine, G. J., and D. P. McManus. 1995. Nucleic acids: vaccines of the future. Parasitol. Today 11:113.
9. Couillin, I., B. Culmannpenciolelli, E. Gomard, J. Choppin, J. P. Levy, J. G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 nef protein. J. Exp. Med. 180:1129.
10. Scalzo, A. A., S. L. Elliott, J. Cox, J. Gardner, D. J. Moss, and A. Suhrbier. 1995. Induction of protective cytotoxic T cells to murine cytomegalovirus using a non-apeptide and a human compatible adjuvant (Montanide ISA 720). J. Virol. 69: 1306.
11. Vitiello, A., G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. LaFond, L. L. Yuan, F. V. Chisari, J. Furze, R. Bartholomeuz, and R. W. Chesnut. 1995. Development of a lipopeptide based therapeutic vaccine to treat chronic HBV infection: induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341.
12. Rabinovich, N. R., P. McInnes, D. L. Klein, and B. F. Hall. 1994. Vaccine technologies: view to the future. Science 265:1401.
13. Del-Val, M., H. J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145.
14. + cytotoxic T cells: implications for polyepitope vaccine design. Proc. Natl. Acad. Sci. USA 92:5845.
15. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:1335.
16. Neisig, A., J. Roelse, A. J. A. Sijts, F. Ossendorp, M. C. W. Feltkamp, W. M. Kast, C. J. M. Melief, and J. J. Neefjes. 1995. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J. Immunol. 154:1273.
17. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
18. Adorini, L., and Z. A. Nagy. 1990. Peptide competition for antigen presentation. Immunol. Today 11:21.
19. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606.
20. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
21. Mo, X. Y., M. Sangster, S. Sarawar, C. Coleclough, and P. C. Doherty. 1995. Differential antigen burden modulates the gamma interferon but not the immunoglobulin response in mice that vary in susceptibility to Sendai virus pneumonia. J. Virol. 69:5592.
22. Lipford, G. B., S. Bauer, H. Wagner, and K. Heeg. 1995. In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability. Vaccine 13:313.
23. Elliott, T., M. Smith, P. Driscoll, and A. McMichael. 1993. Peptide selection by class I molecules of the major histocompatibility complex. Curr. Biol. 3:854.
24. b-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen. J. Virol. 69:3134.
25. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs. Immunogenetics 41:178.
26. Elliott, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
27. Oldstone, M. B. A., A. Tishon, M. Eddleston, J. C. Delatorre, T. McKee, and J. L. Whitton. 1993. Vaccination to prevent persistent viral infection. J. Virol. 67: 4372.
28. Whitton, J. L., N. Sheng, M. B. Oldstone, and T. A. McKee. 1993. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:348.
29. Kara, U., D. Pye, R. Lord, C. Pam, H. Gould, M. Geysen, G. Jones, D. Stenzel, C. Kidson, and A. Saul. 1989. Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from Plasmodium falciparum. J. Immunol. 143:1334.
30. Both, G. W., M. E. Andrew, D. B. Boyle, B. E. Coupar, and A. R. Bellamy. 1992. Relocation of antigens to the cell surface membrane can enhance immune stimulation and protection. Immunol. Cell Biol. 70:73.